Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
Clinical trial NCT00707707 · COMPLETED
Trial details
- NCT number
- NCT00707707
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-15
- Primary completion
- 2009-11-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.